Could a pain device help rare brain disease sufferers?
NCT ID NCT05653778
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether scrambler therapy, a device that uses mild electrical signals on the skin, can reduce nerve pain in people with corticobasal syndrome (CBS). Twenty-five adults with CBS and moderate-to-severe pain will be randomly assigned to receive either scrambler therapy or standard TENS treatment. The main goal is to see if pain scores drop by at least one-third after one month, which would support larger future trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Scrambler therapy (device) and TENS (device)
- What this could lead to
- If it works, this could point toward a non-drug way to manage nerve pain in corticobasal syndrome.
- What could go wrong
- This is a very small pilot study (25 people) with no blinding, so results may not be reliable or apply to others. Pain relief may be temporary or no better than TENS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORTICOBASAL DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins School of Medicine
RECRUITINGBaltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- High-Resolution brain scans aim to unmask Tau's role in Parkinson's
- PET scans reveal hidden brain inflammation in rare movement disorder
- Scientists decode gait signatures to spot brain diseases
- Experimental drug aims to curb disinhibition in dementia patients
- New quick tests may unlock secrets of brain disease